Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001493152-24-052488
Filing Date
2024-12-30
Accepted
2024-12-30 16:18:32
Documents
1
Period of Report
2024-12-27

Document Format Files

Seq Description Document Type Size
1 ownership.html 4  
1 ownership.xml 4 4269
  Complete submission text file 0001493152-24-052488.txt   5842
Mailing Address 455 E. MEDICAL CENTER BLVD SUITE 300 SUITE 300 HOUSTON TX 77598
Business Address 455 E. MEDICAL CENTER BLVD SUITE 300 HOUSTON TX 77598 281-671-5150
FibroBiologics, Inc. (Issuer) CIK: 0001958777 (see all company filings)

EIN.: 863329066 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O FIBROBIOLOGICS, INC. 455 E. MEDICAL CENTER BLVD., SUITE 300 HOUSTON TX 77598
Business Address
GARCIA RUBEN A (Reporting) CIK: 0002013617 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-41934 | Film No.: 241590096